Reviva Pharmaceuticals Holdings, Inc. (RVPHW) Financials

RVPHW Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 5.4 million 13.9 million
June 30, 2023 11.8 million 10.2 million
March 31, 2023 12.9 million 7.1 million
Dec. 31, 2022 18.9 million 6.6 million

RVPHW Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -6.2 million 350410
June 30, 2023 -5.3 million 2.6 million
March 31, 2023 -8.0 million 51527
Dec. 31, 2022 -4.7 million 56586

RVPHW Net Income

No data available :(

RVPHW Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 5.0 million - -
June 30, 2023 11.2 million - -
March 31, 2023 11.3 million - -
Dec. 31, 2022 18.5 million - -

RVPHW Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 24.0 million
June 30, 2023 22.4 million
March 31, 2023 21.8 million
Dec. 31, 2022 19.5 million

RVPHW Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 8.7 million 2.0 million -
June 30, 2023 - 9.0 million 3.1 million -
March 31, 2023 - 5.2 million 1.5 million -
Dec. 31, 2022 - 6.3 million 1.5 million -

RVPHW Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - -
June 30, 2023 - -
March 31, 2023 - -
Dec. 31, 2022 - -

RVPHW

Price: $0

52 week price:
0.00
0.04

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 32413

Market Capitalization: 343911

Links: